We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $500B Turnover 17.06%
1-Year Est. Return 36.84%
 

Barclays is a British universal bank whose roots go back to 1690, when the Quakers John Freame and Thomas Gould started a goldsmith banking business in London. The Barclays name came into the business in 1736, when James Barclay, son-in-law of founder John Freame, became a partner. Barclays launched the UK's first credit card, Barclaycard, in 1966, and in 1967 put the world's first cash machine in a branch in Enfield. In 2008 Barclays bought the North American operations of Lehman Brothers, and in 2009 it sold its Barclays Global Investors unit, home of the iShares ETFs, to BlackRock. It runs five divisions: UK consumer banking, UK corporate banking, private banking and wealth management, an investment bank and a US consumer bank.

This Fund
S&P 500
This Quarter Est. Return
+0.96%
1 Year Est. Return
+36.84%
3 Year Est. Return
+152.89%
5 Year Est. Return
+181.78%
10 Year Est. Return
+662.03%
AUM
$500B
AUM Growth
-$20.6B
Cap. Flow
-$19B
Cap. Flow %
-3.79%
Top 10 Hldgs %
39.98%
Holding
5,855
New
525
Increased
2,900
Reduced
1,494
Closed
474
Avg Time Held Equity + Options
5.6 years
Top 10 Avg Time Held Equity + Options
2.2 years
Top 20 Avg Time Held Equity + Options
2.9 years
Avg Time Held Equity only
6.5 years
Top 10 Avg Time Held Equity only
4.6 years
Top 20 Avg Time Held Equity only
5 years

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$17.5B
2
NVDA icon
NVIDIA
NVDA
+$2.7B
3
INTC icon
Intel
INTC
+$1.98B
4
AVGO icon
Broadcom
AVGO
+$1.46B
5
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$1.11B

Sector Composition

Rank Sector Weight
1 Miscellaneous 49.47%
2 Technology 19.84%
3 Consumer Discretionary 7.61%
4 Financials 5.61%
5 Communication Services 3.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
CELZ icon
5351
Creative Medical Technology
CELZ
$4.72M
– –
-54
Closed -$78 –
CFG icon
5352
PUT
Citizens Financial Group
CFG
$26.5B
– –
-100,000
Closed -$7.01M –
CGEN icon
5353
Compugen
CGEN
$186M
– –
-2,906
Closed -$6.22K –
CHDN icon
5354
PUT
Churchill Downs
CHDN
$6.71B
– –
-845,000
Closed -$75.7M –
CLBK icon
5355
Columbia Financial
CLBK
$2.99B
– –
-45,434
Closed -$438K –
CLIR icon
5356
ClearSign Technologies
CLIR
$16.1M
– –
-33
Closed -$121 –
CLNN icon
5357
Clene
CLNN
$56.9M
– –
-227
Closed -$1.4K –
CLOZ icon
5358
Panagram BBB-B CLO ETF
CLOZ
$705M
– –
-194,400
Closed -$5.14M –
CLRB icon
5359
Cellectar Biosciences
CLRB
$11.8M
– –
-561
Closed -$1.56K –
CLS icon
5360
CALL
Celestica
CLS
$26.1B
– –
-25,000
Closed -$9.12M –
CMCT icon
5361
Creative Media & Community Trust
CMCT
$11.9M
– –
-8
Closed -$26 –
CME icon
5362
CALL
CME Group
CME
$109B
– –
-8,000
Closed -$1.77M –
CME icon
5363
PUT
CME Group
CME
$109B
– –
-8,000
Closed -$1.77M –
CMI icon
5364
PUT
Cummins
CMI
$62B
– –
-40,000
Closed -$28.5M –
CNVS icon
5365
Cineverse
CNVS
$40.5M
– –
-2
Closed -$6 –
COCP icon
5366
Cocrystal Pharma
COCP
$20M
– –
-42
Closed -$44 –
COHN icon
5367
Cohen & Co
COHN
$32.9M
– –
-66
Closed -$896 –
COHU icon
5368
CALL
Cohu
COHU
$1.82B
– –
-12,800
Closed -$946K –
VISN icon
5369
CALL
Vistance Networks Inc
VISN
$1.27B
– –
-700,000
Closed -$8.95M –
VISN icon
5370
PUT
Vistance Networks Inc
VISN
$1.27B
– –
-100,000
Closed -$1.28M –
CPRX icon
5371
DELISTED
Catalyst Pharmaceutical
CPRX
– –
-41,602
Closed -$1.31M –
CR icon
5372
PUT
Crane Co
CR
$11.6B
– –
-91,200
Closed -$20.3M –
CRDL icon
5373
Cardiol Therapeutics
CRDL
$121M
– –
-300
Closed -$318 –
CRIS icon
5374
Curis
CRIS
$2.2M
– –
-349
Closed -$3.64K –
CRNX icon
5375
DELISTED
Crinetics Pharmaceuticals
CRNX
– –
-122,451
Closed -$4.58M –

Similar funds

Barclays's Q3 2026 Portfolio in Review

As of Q3 2026, Barclays held 5,855 positions worth $500B, down 4% from $521B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Barclays withdrew a net $19B in Q3 2026, closing 474 positions and reducing 1,494 holdings. Its most notable exit was ExxonMobil, an estimated $761M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, down from 55% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Barclays opened a new position in iShares Broad USD High Yield Corporate Bond ETF worth $199M.

  • Barclays's largest Q3 2026 buy was iShares Broad USD High Yield Corporate Bond ETF: 5,582,517 shares worth $199M.
  • Barclays added most to Tesla in Q3 2026, an estimated $17.5B increase.
  • Barclays's biggest Q3 2026 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $35.8B.
  • Barclays fully exited ExxonMobil in Q3 2026, selling an estimated $761M.
  • Barclays's ten largest holdings make up 40% of its $500B portfolio in Q3 2026.
  • Barclays opened 525 new positions and closed 474 in Q3 2026.
  • Barclays's portfolio value fell 4% quarter-over-quarter to $500B.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.